Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) have received a consensus rating of "Moderate Buy" from the twenty ratings firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $588.95.

A number of research analysts have weighed in on the stock. Citigroup reaffirmed a "buy" rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. Evercore ISI cut their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday, April 23rd. Finally, Truist Financial cut their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $521.63 on Thursday. Intuitive Surgical has a 52-week low of $413.82 and a 52-week high of $616.00. The firm has a 50 day moving average price of $530.03 and a 200 day moving average price of $536.86. The stock has a market cap of $186.96 billion, a P/E ratio of 76.49, a P/E/G ratio of 5.55 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the firm posted $1.50 earnings per share. Analysts predict that Intuitive Surgical will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 215 shares of the company's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $549.06, for a total value of $118,047.90. Following the transaction, the senior vice president now directly owns 1,768 shares in the company, valued at approximately $970,738.08. This represents a 10.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction dated Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock worth $2,611,577 over the last ninety days. Insiders own 0.70% of the company's stock.

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently modified their holdings of the business. Onefund LLC grew its stake in shares of Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after acquiring an additional 18 shares in the last quarter. AlphaCore Capital LLC grew its stake in shares of Intuitive Surgical by 4.2% in the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after acquiring an additional 18 shares in the last quarter. Parkside Financial Bank & Trust grew its stake in Intuitive Surgical by 2.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 747 shares of the medical equipment provider's stock worth $390,000 after buying an additional 19 shares in the last quarter. Accredited Investors Inc. grew its stake in Intuitive Surgical by 1.9% during the fourth quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock worth $543,000 after buying an additional 19 shares in the last quarter. Finally, Second Line Capital LLC grew its stake in Intuitive Surgical by 3.4% during the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after buying an additional 19 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.